Opendata, web and dolomites

IMPACT SIGNED

Improving DNA Analysis for Correct Healthcare

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IMPACT project word cloud

Explore the words cloud of the IMPACT project. It provides you a very rough idea of what is the project "IMPACT" about.

samplix    estate    profitability    mental    selling    strive    site    generation    trade    over    commercial    full    core    scientists    musd    opposed    barriers    total    biological    amount    launch    raised    biopsies    plan    capital    engaged    droplet    sales    aggregated    strategy    disorders    drug    despite    genetics    xdrop    overcome    revolutionized    put    consumables    oem    biology    constituting    instrument    medical    shortcomings    operate    place    molecular    2019    tumour    sequencing    return    bioinformatics    blade    healthcare    single    providers    microfluidics    molecule    cancer    globe    diagnosis    families    agreements    freedom    encompasses    razor    revenue    team    millions    round    financing    minute    dna    resolution    gt    immunological    installing    droplets    2018    subscription    complexity    diseases    subsequent    multibillion    brings    patent    bigger    retrieve    bulk    free    preparation    reaction    proprietary    qualify    market    chamber    material    molecules    personalized   

Project "IMPACT" data sheet

The following table provides information about the project.

Coordinator
SAMPLIX ApS 

Organization address
address: MILEPARKEN 28
city: HERLEV
postcode: 2730
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 2˙669˙623 €
 EC max contribution 1˙868˙736 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAMPLIX ApS DK (HERLEV) coordinator 1˙868˙736.00

Map

 Project objective

Over the past 10 years DNA sequencing has revolutionized how we apply genetics in personalized healthcare, diagnosis and drug development despite that the sequencing technology comes with numerous shortcomings. Samplix has developed a proprietary technology, Xdrop™, which addresses these shortcomings. Samplix’ technology encompasses state of the art microfluidics, molecular biology and bioinformatics. The Xdrop technology enables scientists and medical personnel to retrieve specific single DNA molecules from a minute amount of biological sample e.g. tumour biopsies, for subsequent DNA sequencing. At the core of the Xdrop technology is the generation of millions of droplets, each droplet constituting a reaction chamber for the sample preparation of single DNA molecules. This is opposed to today’s technology which is based on bulk preparation of sample material for DNA sequencing. Single molecule resolution is key to understanding the complexity of major diseases such as cancer, immunological diseases, mental disorders, etc. The proposed project addresses the need to qualify known market barriers and put measures in place to overcome such market barriers. Samplix has engaged a very experienced management team with an aggregated experience of >50 years in developing and selling products for DNA analysis. Samplix has already established: • 5 test site agreements with leading DNA institutions around the globe • Agreements with leading OEM providers on instrument and consumables • A patent estate of 5 patent families. • Freedom to operate in multibillion € market. At Samplix, we strive at 100 mUSD in revenue and profitability in year five after full commercial launch. To achieve such an ambitious goal, we plan to apply a razor/razor blade sales strategy by installing the instrument “for free” in return for a subscription to consumables Samplix raised 4,5 m€ in May 2018 which brings the total capital raised to 8 m€. A bigger financing round is planned for 2019.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMPACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More